Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case of dermatomyositis in a patient with central core disease: unusual association with autoimmunity and genetic muscle disease. | Pediatr Rheumatol Online J | 2021 | 34193198 | PubTator, text mining | PubMed |
| Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. | Neurol Sci | 2021 | 34189662 | PubTator, text mining | PubMed |
| Evaluating an In-House Cell-Based Assay for Detecting Antibodies Against Muscle-Specific Tyrosine Kinase in Myasthenia Gravis. | J Clin Neurol | 2021 | 34184448 | PubTator, text mining | PubMed |
| Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma. | Cureus | 2021 | 34178496 | PubTator, text mining | PubMed |
Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism. | Front Neurol | 2021 | 34177770 | PubTator, text mining | PubMed |
| Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. | J Immunother Cancer | 2021 | 34172516 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations. | Front Immunol | 2021 | 34163474 | PubTator, text mining | PubMed |
| Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia. | Nature | 2021 | 34163073 | PubTator, text mining | PubMed |
| Diagnostic yields and clinical features of ocular myasthenia gravis. | Medicine (Baltimore) | 2021 | 34160444 | PubTator, text mining | PubMed |
| Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study. | Clin Neurophysiol | 2021 | 34147009 | PubTator, text mining | PubMed |
| Pediatric Paroxysmal Exercise-Induced Neurological Symptoms: Clinical Spectrum and Diagnostic Algorithm. | Front Neurol | 2021 | 34140924 | PubTator, text mining | PubMed |
| Myasthenic crisis appearing after resection of intracardiac ectopic thymoma with superior vena cava syndrome. | Surg Case Rep | 2021 | 34131826 | PubTator, text mining | PubMed |
| The roles of integrins in cancer. | Fac Rev | 2021 | 34131655 | PubTator, text mining | PubMed |
| Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans. | Vaccine | 2021 | 34127298 | PubTator, text mining | PubMed |
| A systematic review of myasthenia gravis complicated with myocarditis. | Brain Behav | 2021 | 34105901 | PubTator, text mining | PubMed |
| Anti-Muscle Specific Kinase (Anti-MuSK) Positive Myasthenia Gravis Overlapping With Parkinson's Disease: A Challenging Diagnosis. | Cureus | 2021 | 34104586 | PubTator, text mining | PubMed |
| Radiological Characteristics of Extraocular Muscles in Myasthenia Gravis Patients with Ocular Manifestations: A Case-Control Study. | Clin Ophthalmol | 2021 | 34103891 | PubTator, text mining | PubMed |
| Helper T Cells in Idiopathic Membranous Nephropathy. | Front Immunol | 2021 | 34093559 | PubTator, text mining | PubMed |
| Bioengineered model of the human motor unit with physiologically functional neuromuscular junctions. | Sci Rep | 2021 | 34083648 | PubTator, text mining | PubMed |
| No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients. | Brain Behav | 2021 | 34075720 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=60